Conmed (CNMD) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $316.6 million.
- Conmed's Accumulated Depreciation & Amortization rose 367.04% to $316.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $316.6 million, marking a year-over-year increase of 367.04%. This contributed to the annual value of $316.6 million for FY2025, which is 367.04% up from last year.
- Conmed's Accumulated Depreciation & Amortization amounted to $316.6 million in Q4 2025, which was up 367.04% from $305.4 million recorded in Q4 2024.
- In the past 5 years, Conmed's Accumulated Depreciation & Amortization ranged from a high of $316.6 million in Q4 2025 and a low of $263.8 million during Q4 2021
- Over the past 5 years, Conmed's median Accumulated Depreciation & Amortization value was $292.2 million (recorded in 2023), while the average stood at $291.1 million.
- Per our database at Business Quant, Conmed's Accumulated Depreciation & Amortization surged by 722.17% in 2021 and then skyrocketed by 367.04% in 2025.
- Over the past 5 years, Conmed's Accumulated Depreciation & Amortization (Quarter) stood at $263.8 million in 2021, then increased by 5.22% to $277.5 million in 2022, then rose by 5.27% to $292.2 million in 2023, then rose by 4.54% to $305.4 million in 2024, then rose by 3.67% to $316.6 million in 2025.
- Its Accumulated Depreciation & Amortization was $316.6 million in Q4 2025, compared to $305.4 million in Q4 2024 and $292.2 million in Q4 2023.